Most Read Articles
Elvira Manzano, 3 days ago
Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.
Jairia Dela Cruz, 3 days ago
For individuals with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
In patients with type 2 diabetes (T2D), postprandial hyperglycaemia and hypertriglyceridemia worsens survival outlook, finds a new study.

Nocturia likely to cause rather than result from depressive symptoms

27 Apr 2020

A bidirectional relationship exists between nocturia and depressive symptoms, a recent study has shown.

Moreover, the cross-lagged path coefficient suggests that nocturia is more likely to be a cause rather than a result of depressive symptoms, according to the investigators.

This longitudinal analysis was part of the Nagahama Cohort Project, a population-based cohort study, with baseline and 5-year follow-up investigations to assess the directional link between nocturia and depressive symptoms in the general population.

The investigators used self-report questionnaires, the International Prostate Symptom Score and the 5-item Mental Health Inventory to measure nocturnal voiding frequency and mental health. They also performed logistic regression and cross-lagged panel analyses to examine the bidirectional relationship between nocturia and depressive symptoms.

Data from 8,285 of 9,764 participants (median age, 57.3 years; 32.0 percent men) at baseline were analysed. New-onset depressive symptoms were observed in 369 participants and nocturia in 793.

Adjusted logistic regression analyses revealed a clear dose-relationship between baseline nocturnal voiding frequency and new-onset depressive symptoms (ptrend<0.001) and a weak association between baseline 5-item Mental Health Inventory and new-onset nocturia (ptrend=0.0087).

In cross-lagged panel analysis, the path coefficient from nocturnal voiding frequency to 5-item Mental Health Inventory (β, –0.06; p<0.001) was stronger compared to that from 5-item Mental Health Inventory to nocturnal voiding frequency (β, –0.02; p=0.047). This suggested that nocturia could more likely be a cause than a result of depressive symptoms.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Psychiatry - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elvira Manzano, 3 days ago
Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.
Jairia Dela Cruz, 3 days ago
For individuals with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
3 days ago
In patients with type 2 diabetes (T2D), postprandial hyperglycaemia and hypertriglyceridemia worsens survival outlook, finds a new study.